GSK
928 hedge funds and large institutions have $14.4B invested in GSK in 2022 Q1 according to their latest regulatory filings, with 103 funds opening new positions, 351 increasing their positions, 274 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.01% more ownership
Funds ownership: 5.21% → 5.22% (+0.01%)
0% less capital invested
Capital invested by funds: $14.4B → $14.4B (-$68M)
11% less funds holding in top 10
Funds holding in top 10: 19 → 17 (-2)
Holders
928
Holding in Top 10
17
Calls
$342M
Puts
$206M
Top Buyers
| 1 | +$132M | |
| 2 | +$103M | |
| 3 | +$101M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$97.1M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$70.2M |
Top Sellers
| 1 | -$121M | |
| 2 | -$107M | |
| 3 | -$83.5M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$65.3M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$57.3M |